Abstract
Wound healing is the process of tissue repair and the tissue response to injury. It is a complex biologic process involving chemotaxis, cellular reproduction, matrix protein, neovascularization, and scar remodeling (1). Much progress has been made in our understanding of the cellular and molecular biology of wound repair and remodeling in recent years, yet many aspects about wound healing remain unclear. Growth factors are polypeptides that control the growth, differentiation, and metabolism of cells and regulate the process of tissue repair (2,3). The role of growth factors in wound healing and specifically in diabetic ulcer healing is the subject of this chapter.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Edington HE. Wound healing, in Basic Science Review for Surgeons (Simmons RL, Steed DL, eds.), WB Saunders, Philadelphia, 1992, pp. 41–55.
McGrath MH. Peptide growth factors and wound healing. Clin Plast Surg 1990;17:421–432.
Rothe MJ, Falanaa V. Growth factors and wound healing. Clin Dermatol 1992;9:553–559.
Steed DL. Mediators of inflammation, in Basic Science Review for Surgeons (Simmons RL, Steed DL, eds.), WB Saunders, Philadelphia, 1992, pp. 12–29.
Grinnel F. Fibronectin and wound healing. Am J Dermatopathol 1982;4:185–192.
Folkman T, Lansburn M. Angiogenic factors. Science 1987;235:442–447.
Knighton DR, Hunt TK, Schewenstuhl A. Oxygen tension regulates the expression of angiogenesis factor by macrophages. Science 1983;221:1283–1290.
Knighton DR, Silver IA, Hunt TK. Regulation of wound healing angiogenesis: effect of oxygen gradients and inspired oxygen concentration. Surgery 1981;90:262–269.
Lynch SE, Nixon JC. Role of platelet-derived growth factor in wound healing: synergistic effects with growth factors. Proc Natl Acad Sci USA 1987;84:7696–7697.
Robson M, Phillips L. Platelet-derived growth factor BB for the treatment of chronic pressure ulcers. Lancet 1992;339:23–25.
Mustoe T, Cutler N. A phase II study to evaluate recombinant platelet-derived growth factor- BB in the treatment of stage 3 and 4 pressure ulcers. Arch Surg 1994;129:212–219.
Steed DL. Diabetic Ulcer Study Group: clinical evaluation of recombinant human plateletderived growth factor for the treatment of lower extremity diabetic ulcers. J Vasc Surg 1995;21:71–81.
Wieman TJ, Smiell JM, Su, Y. Efficacyand safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers. A phase III randomized placebo-controlled double-blind study. Diabetes Care 1998;21:822–827.
Wieman TJ. Clinical efficacy of becaplermin (rhPDGF-BB) gel. Becaplermin Gel Studies Group. Am J Surg 1998;176(Suppl 2A):74S–79S.
Sporn MB, Robert AB. Transforming growth factor. JAMA 1989;262:938–941.
McPherson J, Pratt B, Steed D, Robson M. Healing of diabetic foot ulcers using transforming growth factor-beta in collagen sponge, in Abstracts of the Meeting of the European Tissue Repair Society, August, 1999.
Brown GL, Curtsinger L, Nanney LB. Enhancement of wound healing by topical treatment with epidermal growth factor. N Engl J Med 1989;321:76–80.
Brown GL, Curtsinger L. Stimulation of healing of chronic wounds by epidermal growth factor. Plast Recontr Surg 1991;88:189–194.
Robson M, Steed D, Jensen J. Keratinocyte growth factor 2 in the treatment of venous leg ulcers, in Abstracts of the World Congress of Wound Healing, September, 2000.
Spencer EM, Skover G, Hunt TK. Somatomedins: do they play a pivotal role in wound healing?, in Growth Factors and Other Aspects of Wound Healing: Biological and Clinical Implications (Barbul A, Pines E, Caldwell M, eds.), Alan R Liss, New York, 1988, pp. 103–106.
Steed DL, Goslen B, Hambley R, et al. Clinical trials with purified platelet releasate, in Clinical and Experimental Approaches to Dermal and Epidermal Repair: Normal and Chronic Wounds (Barbul A, ed.), Alan R Liss, New York, 1990, pp. 103–113.
Knighton DR, Ciresi KF. Classifications and treatment of chronic nonhealing wounds. Ann Surg 1986;104:322–330.
Knighton DR, Ciresi K. Stimulation of repair in chronic, nonhealing, cutaneous ulcers using platelet-derived wound healing formula. Surg Gynecol Obstet 1990;170:56–60.
Atri SC, Misra J. Use of homologous platelet factors in achieving total healing of recalcitrant skin ulcers. Surgery 1990;108:508–512.
Holloway GA, Steed DL, DeMarco MJ, et al. A randomized controlled dose response trial of activated platelet supernatant topical CT-102 (APST) in chronic nonhealing wounds in patients with diabete melitus. Wounds 1993;5:198–206.
Krupski WC, Reilly LM. A prospective randomized trial of autologous platelet-derived wound healing factors for treatment of chronic nonhealing wounds: a preliminary report. J Vasc Surg 1991;14:526–532.
Steed DL, Goslen JB, Holloway GA. CT-102 activated platelet supernatant, topical versus placebo: a randomized prospective double blind trial in healing of chronic diabetic foot ulcers. Diabetes Care 1992;15:1598–1604.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer Science+Business Media New York
About this chapter
Cite this chapter
Steed, D.L. (2002). Role of Growth Factors in the Treatment of Diabetic Foot Ulceration. In: Veves, A., Giurini, J.M., LoGerfo, F.W. (eds) The Diabetic Foot. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-168-8_18
Download citation
DOI: https://doi.org/10.1007/978-1-59259-168-8_18
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61737-253-7
Online ISBN: 978-1-59259-168-8
eBook Packages: Springer Book Archive